IPSC Century Therapeutics, Inc.
Nasdaq · SEC CIK 1850119 · EDGAR
- Bought, last 12 months
- $97.0K 3 purchases by 2 insiders
- Sold, last 12 months
- $86.1K 20 sales by 4 insiders
- Filings on record
- 152 since 2021-12-28, latest 2026-09-15 18:25
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Pfeiffenberger Brent | Pres, CEO, Dir | $47.7K | $14.6K |
| Cowan Chad | CSO | $49.4K | $2,731 |
| Russotti Gregory | See Remarks | — | $40.2K |
| Carr Douglas | SVP Fin, Ops | — | $28.6K |
Transactions 113
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | 2023-05-15 | IPSC | Carr Douglas | SVP Fin, Ops | A - Grant | $0.00 | +120.8K | 321.4K | +60% | $0 | |
| 2023-05-17 | 2023-05-15 | IPSC | Diem Michael Craig | CFO | A - Grant | $0.00 | +151.1K | 274.3K | +123% | $0 | |
| D | 2023-04-05 | 2023-04-03 | IPSC | Borges Luis | CSO | M - OptEx | $1.03 | +7,452 | 256.5K | +3% | +$7,676 |
| DM | 2023-03-23 | 2023-03-21+ | IPSC | Borges Luis | CSO | S - Sale+OE | $3.72 | -144.9K | 43.8K | -77% | -$539.6K |
| DM | 2023-03-23 | 2023-03-21+ | IPSC | Borges Luis | CSO | M - OptEx | $1.03 | +350.2K | 109.4K | New | +$360.8K |
| DM | 2023-02-06 | 2023-02-02 | IPSC | Farid Adrienne | Chief Ops Off | A - Grant | $0.00 | +43.8K | 96.1K | +84% | $0 |
| DM | 2023-02-06 | 2023-02-02 | IPSC | Carr Douglas | VP Fin, Ops | A - Grant | $0.00 | +15.0K | 193.0K | +8% | $0 |
| DM | 2023-02-06 | 2023-02-02 | IPSC | Borges Luis | CSO | A - Grant | $0.00 | +43.8K | 21.9K | New | $0 |
| DM | 2023-02-06 | 2023-02-02 | IPSC | Diem Michael Craig | Chief Business Off | A - Grant | $0.00 | +43.8K | 101.4K | +76% | $0 |
| 2022-08-11 | 2022-08-09 | IPSC | Versant Vantage II GP, L.P. | 10% | J - Other | $0.00 | -364.8K | 11.45M | -3% | $0 | |
| 2022-08-11 | 2022-08-09 | IPSC | Versant Vantage II GP, L.P. | 10% | S - Sale | $13.03 | -550.0K | 11.82M | -4% | -$7.17M | |
| 2022-02-02 | 2022-01-31 | IPSC | Versant Ventures VI GP-GP, LLC | 10% | J - Other | $0.00 | -179.0K | 12.37M | -1% | $0 | |
| 2021-12-28 | 2021-12-23 | IPSC | Versant Vantage II, L.P. | 10% | J - Other | $0.00 | -371.0K | 12.55M | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations